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The glutamatergic subthalamic nucleus (STN) exerts control over motor output through nuclei of the basal ganglia. High-frequency
electrical stimuli in the STN effectively alleviatemotor symptoms inmovement disorders, and cholinergic stimulation boosts this effect.
To gain knowledge about the mechanisms of cholinergic modulation in the STN, we studied cellular and circuit aspects of nicotinic
acetylcholine receptors (nAChRs) inmouseSTN.Wediscovered two largelydivergentmicrocircuits in theSTN; these are regulated inpart
by either42 or7 nAChRs. STN neurons containing42 nAChRs (42 neurons) receivedmore glutamatergic inputs, and prefer-
entially innervated GABAergic neurons in the substantia nigra pars reticulata. In contrast, STN neurons containing 7 nAChRs (7
neurons) receivedmore GABAergic inputs, and preferentially innervated dopaminergic neurons in the substantia nigra pars compacta.
Interestingly, local electrical stimuli excited a majority (79%) of 42 neurons but exerted strong inhibition in 58% of 7 neurons,
indicating an additional diversity of STN neurons: responses to electrical stimulation. Chronic exposure to nicotine selectively affects
42nAChRs in STN: this treatment increased thenumber of42neurons, upregulated4-containingnAChRnumber and sensitivity,
and enhanced the basal firing rate of 42 neurons both ex vivo and in vivo. Thus, chronic nicotine enhances the function of the
microcircuit involving42nAChRs. This indicates chronic exposure to nicotinic agonist as a potential pharmacological intervention to
alter selectively thebalancebetween these twomicrocircuits, andmayprovide ameans to inhibit substantianigradopaminergic neurons.
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Introduction
The subthalamic nucleus (STN), through glutamatergic syn-
apses, governs two output nuclei of the basal ganglia: the internal
segment of the globus pallidus and the substantia nigra pars re-
ticulata (SNr) (Smith andParent, 1988;Heida et al., 2008;Marani
et al., 2008). Parkinson’s disease (PD) is caused by the death of
dopaminergic (DA) neurons in the substantia nigra pars com-
pacta (SNc) and is characterized by motor symptoms, such as
resting tremor, rigidity, bradykinesia, and akinesia. STN neurons
in PD show abnormal activity, including accelerated, burst, and
synchronized firing, which are correlated with motor symptoms
(Bergman et al., 1994; Wichmann et al., 1994; Kreiss et al., 1997;
Magnin et al., 2000; Perlmutter and Mink, 2006; Weinberger et
al., 2009). Dopamine compensation with L-dopa or apomor-
phine relieves motor symptoms and restores normal activity in
STN neurons (Kreiss et al., 1997; Levy et al., 2001, 2002; Wein-
berger et al., 2006). As PD progresses, L-dopa efficacy decreases;
however, increasing L-dopa dosage causes motor fluctuations
and dyskinesia (Perlmutter andMink, 2006; Cenci, 2007; Poewe,
2009). Therefore, it is important to identify other therapies aim-
ing to enhance ormaintain L-dopa efficacy tominimize these side
effects.
Deep brain stimulation (DBS) in the STN not only improves
themajormotor symptoms of PDbut also reduces required doses
of L-dopa and mitigates motor fluctuations and dyskinesia (Nutt
et al., 2001; Breit et al., 2004; Perlmutter andMink, 2006; Benabid
et al., 2009; Gradinaru et al., 2009). Cholinergic neurons in the
pedunculopontine tegmental nucleus (PPTg) project to STN
(Ichinohe et al., 2000; Benarroch, 2008), and clinical data show
that stimulating these neurons boosts the therapeutic effects of
STN DBS (Stefani et al., 2007). Additionally, long-term use of
nicotinic agonists potentiates the ability of L-dopa to improve
motor symptoms (Schneider et al., 1998; Domino et al., 1999)
and attenuates L-dopa-induced dyskinesia (Quik et al., 2007;
Bordia et al., 2008; Huang et al., 2011). These facts suggest that
cholinergic agonists and DBS may target the same neuron types
in STN.
Nicotinic acetylcholine receptors (nAChRs) in the basal gan-
glia help to govern voluntary movement (Dani and Bertrand,
2007; Miwa et al., 2011; Quik and Wonnacott, 2011). Mice car-
rying gain-of-function or null mutations in nAChR subunits al-
Received Aug. 17, 2014; revised Jan. 5, 2015; accepted Jan. 14, 2015.
Author contributions: C.X., Y.W., andH.A.L. designed research; C.X. and Y.W. performed research; P.D. and S.L.M.
contributedunpublished reagents/analytic tools; C.X. andH.A.L. analyzeddata; C.X., J.M.M., B.J.H., andH.A.L.wrote
the paper.
This work was supported by National Institutes of Health Grants DA17279, AG033954, and R21DA033831, and
the California Tobacco-Related Disease Research ProgramGrants 16FT-0066, 17RT-0127, and 19KT-0032.We thank
Raad Nashmi and Haijiang Cai for comments and discussion.
The authors declare no competing financial interests.
Correspondence should be addressed to Dr. Henry A. Lester,Mail code 156-29, California Institute of Technology,
1200 East California Blvd, Pasadena, CA 91125. E-mail: lester@caltech.edu.
DOI:10.1523/JNEUROSCI.3528-14.2015
Copyright © 2015 the authors 0270-6474/15/353734-13$15.00/0
3734 • The Journal of Neuroscience, March 4, 2015 • 35(9):3734–3746
low selective activation or deletion of certain nAChR subtypes in
vivo (Champtiaux and Changeux, 2002; Lester et al., 2003). Stud-
ies using these mouse lines implicate nAChRs containing 4, 6,
and2 subunits in the control ofmovement (Labarca et al., 2001;
Tapper et al., 2004; Drenan et al., 2008, 2010; Drenan and Lester,
2012). It is well established that these nAChRsmodulate neuronal
activity and neurotransmitter release in the SN and the striatum
(Nashmi et al., 2007; Drenan et al., 2008, 2010; Xiao et al., 2009a;
Quik andWonnacott, 2011). However, how these nAChRs regu-
late other nuclei in the basal ganglia is understood poorly.
Although several nAChR subunit mRNAs and binding sites
have been detected in the STN (Cimino et al., 1992; Quik et al.,
2000; Pimlott et al., 2004), it remains unclear whether nAChRs
subtypes modulate the divergent outputs of STN neurons and
whether chronic exposure to nicotine regulates these nAChRs
and modifies neural circuits. In this study, we addressed these
questions.
Materials andMethods
The care and use of animals and the experimental protocol of this study
were approved by the Institutional Animal Care and Use Committee of
the California Institute of Technology. Efforts were made to minimize
animal suffering and to minimize the number of animals used.
Electrophysiological recordings: brain slice preparation. The recordings
were performed using brain slices, which were prepared from 7- to 11-
week-old C57BL/6 (wild-type) mice, nAChR 4-YFP, or 4 subunit
knock-out mice, using the protocol described with some modifications
(Ye et al., 2006; Xiao et al., 2009a, b). Both4-KO and4-YFPmice were
backcrossed N10 to C57BL/6. In brief, the mice were killed with CO2
and were subject to cardiac perfusion with ice-cold modified glycerol-
based artificial CSF saturated with 95%O2/5%CO2 (carbogen) contain-
ing the following (in mM): 250 glycerol, 2.5 KCl, 1.2 NaH2PO4, 1.2
MgCl2, 2.4 CaCl2, 26 NaHCO3, and 11 glucose. The brain was subse-
quently removed and sliced with a microslicer (DTK-1000, Ted Pella) or
a Compresstome (VH-200, Precisionary) while immersed in modified
glycerol-based artificial CSF. To retain the connection between STN and
the substantia nigra (SN), we cut parasagittal slices (350 m) with an
inward angle of 10°-14° toward the forebrain. Brain slices, containing
STN and the SN, were allowed to recover at 32°C in a holding chamber
filled with carbogenated artificial CSF, containing the following (inmM):
125NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2MgCl2, 2.4 CaCl2, 26NaHCO3, and
11 glucose. One hour later, the holding chamber with slices was placed
at room temperature. One of the slices was transferred into the re-
cording chamber and superfused (1.5–2.0 ml/min) with carbogen-
saturated artificial CSF at 32  0.5°C. Three or four slices per mouse
were used for recordings.
Patch-clamp recording. The neurons were visualized with an upright
microscope (BX50WI; Olympus) and near infrared or blue illumination
(the latter for visualizing fluorescent proteins). Single or dual whole-cell
patch-clamp techniques were used to record electrophysiological signals
from neurons with MultiClamp 700B amplifiers (Molecular Devices),
Digidata 1322 analog-to-digital converters (Molecular Devices), and
pClamp 9.2 software (Molecular Devices). Data were sampled at 10 kHz
and filtered at 2 kHz. A patch electrode had a resistance of 4–6 M, when
filled with intrapipette solutions: solution 1 (in mM, for most experi-
ment): 135Kgluconate, 5KCl, 5 EGTA, 0.5CaCl2, 10HEPES, 2Mg-ATP,
and 0.1 GTP; solution 2 (in mM, for particular experiments as stated): 70
K gluconate, 65 KCl, 5 EGTA, 0.5 CaCl2, 10HEPES, 2Mg-ATP, 0.1 GTP,
and 2 mM QX-314. The pH of these solutions was adjusted to 7.2 with
Tris-base, and their osmolarity was adjusted to 300 mOsm with sucrose.
The junction potential between patch pipette and bath solutions was
nulled just before gigaseal formation. Series resistance was monitored
without compensation throughout the experiment using theMulticlamp
700B. The data were discarded if the series resistance (15–30 M)
changed by20% during whole-cell recordings.
The bath was continually perfused with artificial CSF. All recordings
were done at a temperature of 32 1°C.
Anterograde neuronal tracing.Male adult C57BL/6 mice (3–4 months
old) were anesthetized with isoflurane (4% for induction, 1.5%–2% for
maintenance), placed on a heating pad, and immobilized on a stereotaxic
frame (Stoelting) (Xiao et al., 2009a). An incision wasmade in the skin of
the head to expose the skull, and a 0.4-mm-diameter hole, centered at 1.5
mm caudal to bregma and 1.5 mm right frommidline, was drilled on the
skull. The dura was torn with a sharp needle. A glass pipette with 50–60
m tip was filled with 3% biotinylated-dextran amine (BDA-10,000, in
saline), an anterograde tracer (Invitrogen), was held on a Hamilton sy-
ringe and mounted onto a microinjector (WPI). BDA (0.1 l) was bilat-
erally injected in a spot (anteroposterior 1.5 mm; lateral 1.5 mm;
dorsoventral 4.8 mm) in 5 min, and the glass pipette was gradually lifted
up after injection. Each mouse was allowed to recover for 21 d before
histology assay.
In vivo single-unit recording. Male adult C57BL/6 mice (3–4 months
old) were anesthetized with chloral hydrate (400mg/kg, i.p.), placed on a
heating pad, andmounted on a stereotaxic frame (Stoelting) (Xiao et al.,
2009a). The skin of the head was opened to expose the skull, and a
2-mm-diameter hole, centered at 1.5 mm caudal to bregma and 1.5 mm
right from midline, was drilled in the skull. The dura was torn with a
sharp needle. Chloral hydrate was intraperitoneally injected at 100 mg/
kg/30 min to maintain deep anesthesia (loss of toe pinch reflex).
Electrodes with a 3 m tip were pulled from thick-wall borosilicate
glass (WPI) with a horizontal micropipette puller (Sutter Instruments).
When filled with 2 M NaCl, the electrodes had resistance of 2–5 M. The
signals were amplified with Axoclamp 2A (Molecular Devices) and
Brownlee Precision (model 440) amplifiers, sampled at 10 kHzwithDigi-
data 1200 (Molecular Devices), controlled by pClamp 9.2 (Molecular
Devices) software.We searched for spikes at the coordinates (lateral: 1.3,
1.5, 1.7 mm; bregma:1.6,1.8,2.0 mm; ventral from bregma: 4.3–
4.75 mm), according to the parasagittal planes in a mouse brain atlas
(Paxinos and Franklin, 2001).
To confirm the recording sites, we added 0.2% neurobiotin in the
intrapipette solution (2 M NaCl), and injected 10 nA (5 min) using an
Axoclamp 2A amplifier, at the end of each experiment. We performed
histochemistry to visualize neurobiotin (see Fig. 5A). The neurobiotin
location was defined according to the mouse brain atlas and was used to
calibrate our recording coordinates.
In some experiments, we applied acetylcholine (ACh) by iontophore-
sis. The recording/stimulating electrode contained 0.5 M ACh in 2 M
NaCl. We applied a 5 nA current to prevent ACh from leaking, and
ACh was applied by 30 nA current injection (Armstrong and Lester,
1979).
Immunohistochemistry. The C57BL/6 mice and 4-YFP mice were
killed with CO2, and subject to cardiac perfusion with 7 ml PBS with
heparin, and then with 35 ml 4% PFA in PBS. The mouse brain was
removed, postfixed in 4%PFA inPBS at 4°C for 2 h, and sectioned into 40
m slices with a Compresstome VH-200 (Precisionary). The slices were
mounted onto microscope slides (Fisher Scientific), dried at room tem-
perature, and frozen at 20°C. GFP antibody was used to detect the
expression levels of 4-YFP or 4-GFP nAChRs, and Alexa-555-
conjugated streptavidin was used to visualize neurobiotin. The brain
sections were thawed and washed twice (10 min each) with cold PBS
(4°C), permeabilized for 45 min in PBS/0.5% saponin, blocked for 45
min in PBS/10% donkey serum, incubated in primary antibodies (1:500,
rabbit anti-GFP IgG, Invitrogen) or streptavidin (1:500) in PBS/4%
donkey serum at 4°C for 18 h, washed 3 times (15 min each) in PBS,
incubated in secondary antibody (1:500, Alexa-488-conjugated don-
key anti-rabbit IgG, Invitrogen) in PBS/4% donkey serum at room
temperature for 1 h. Samples were washed 3 times (10 min each) in
PBS, dried at room temperature, and coverslipped with mounting
medium (Vector Laboratories).
Chronic nicotine treatment. Nicotine or vehicle (saline) was adminis-
tered to mice (5- to 6-week-old) by subcutaneously implanted osmotic
minipumps (model 1002 or 2002, Alzet) for 7 or 14 d to avoid repetitive
handling, which causes stress (Marks et al., 1992; Collins et al., 1994;
Marks et al., 2004; Nashmi et al., 2007). On the day of minipump im-
plantation, vehicle or () nicotine hydrogen tartrate was prepared
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freshly and loaded into the pump to deliver
vehicle or nicotine (2 mg/kg/h at 0.5 l/h).
Chemicals and applications. Sigma-Aldrich
furnished most of the chemicals: acetylcholine
Cl (ACh); atropine sulfate; 1(S), 9(R)-(-)-
bicuculline methiodide; CNQX; dihydro--
erythroidine hydrobromide (DHE);
Li DL-2-amino-5-phosphonovalerate; methyl-
lycaconitine citrate (MLA); ()-nicotine
hydrogen tartrate (CAS 65-31-6, nicotine);
RJR-2403; and SR-95531 (GABAzine). PNU-
282987 and tetrodotoxin were purchased from
Tocris Bioscience. Stock solutions (1000)
were aliquoted and stored at20°C. The final
dilutions were freshly made before experi-
ments and were applied by either puffing or
perfusion.
Data analysis. Using Clampfit 9.2, we mea-
sured the peak amplitude of nicotinic currents,
ePSCs, eIPSCs, and eEPSCs, and counted and
analyzed sIPSCs and sEPSCs and firings. The
decay time constants of nicotinic currents were
obtained by single-exponential fitting after the
signals were low-pass filtered at 1 kHz. The am-
plitude of eIPSCs, eEPSCs, and ePSCs was av-
eraged from 4 to 8 traces evoked by stimuli
with the same intensity. The sIPSCs, sEPSCs,
and action potentials were selected by “tem-
plate search,” in which the template was first
selected visually according to its rise and decay
phase, and the criterion level was set to 4 for
sIPSCs/sEPSCs, and 10 for action potentials.
Nicotinic currents, sIPSCs, sEPSCs, eIPSCs, eE-
PSCs, and firing rates between two groups of neurons were compared with
unpaired t test, Mann–Whitney rank test, or Kolmogorov–Smirnov (K-S)
test. Two-way repeated-measures ANOVAwas used to analyze the attenu-
ation of two types of IACh during nicotine exposure.
For analysis of drug effects, frequency of sEPSCs and firings was nor-
malized to the baseline frequency, which was obtained during the initial
control period (2min). Themean frequency during drug applicationwas
measured at the peak of the drug response. Drug effects were expressed as
percentage changes (mean SEM) from baseline. The statistical signif-
icance of drug effects was assessed by a paired two-tailed t test. A two-
tailed Student’s t test was used to evaluate the statistical significance of
differences in drug effects (percentage change from baseline) between
different situations. The  2 test was used to compare the difference in the
incidence of drug responsiveness (e.g., occurrence of inward currents
and increase of firing rate) between different groups of neurons.
The statistical analyses were performed with the aid of SigmaPlot 11.0
(SPSS) andOpenEpi Version 2.3.1 (Dean et al., 2010). Values of p 0.05
were considered significant.
Results
42* and7 nAChRsmediate distinct nicotinic responses
in STN neurons
To investigate the heterogeneity of STN neurons, we examined
ACh responses by directly applying ACh onto STN neurons in
parasagittal mouse brain slices (Fig. 1). We added 0.5 M atro-
pine in both the puffing solution and the perfusate to blockmus-
carinic ACh receptor activation.We detected two types of inward
currents with nonoverlapping ranges of decay time constants:
347  29 ms (n  30) (Fig. 1A1) and 64  5 ms (n  67) (Fig.
1B1), in 21% and 40% of neurons, respectively. The large major-
ity of STN neurons showed spontaneous firing, and ACh appli-
cation transiently increased firing rates (Fig. 1A2,B2). The kinetics
of the firing rate responses resembled those of the two classes of
ACh-evoked currents (IACh) (Fig. 1A1,A2,B1,B2). These data indi-
cate that in the STN there are at least two subtypes of nAChRs
with dramatically different kinetics. Moreover, the activation of
these receptors can modulate STN neurons on either the subsec-
ond or second time scales. Additionally, we observed that 0.5 M
TTX and 20 M CNQX did not change the amplitude of IACh
(faster component: 99 4% of control, n 5, p 0.83; slower
component: 102 5%of control, n 7, p 0.51). This indicates
that these currents are mainly mediated by somatodendritic
nAChRs, but not by presynaptic nAChRs in axonal terminals,
which often facilitate neurotransmitter release (Dani and Ber-
trand, 2007; Exley and Cragg, 2008; Miwa et al., 2011).
A current decay that begins during the agonist application,
then, outlasts the application, may occur by three mechanisms:
receptordesensitization,deactivationof receptorsdue toagonistdis-
sociation, agonist diffusion, or by a combination of these factors.
Therefore, we sought to exclude the contribution of agonist dis-
sociation or diffusion in the acute ACh experiments, by applying
ACh for 3 s (Fig. 1C,D), so that the desensitization of nAChRs can
be assessed in the sustained presence of ACh. Extending ACh
application from 0.1 to 3 s prolonged the current decay by two-
fold to threefold, and also magnified the contrast between decay
times of the two distinct neuronal populations that exhibit the
faster and slower ACh currents. With prolonged agonist ap-
plication, the two average time constants differed by 	9-fold
(Fig. 1E).
nAChRs are pentameric ligand-gated ion channels and are
composed of various combinations of subunits (Wooltorton et al.,
2003; Xiao et al., 2009a; Changeux, 2010). The nAChRs containing
42 or 7 subunits are widely expressed in the CNS. They have
different decay times, sensitivities to nicotine, and desensiti-
zation properties. To determine whether 42 or 7-
containing nAChRsmediate the slower or faster-decaying IACh
Figure 1. Two classes of nicotinic ACh responses in STN neurons. A1, A2, In some STN neurons, ACh puffs (300M, 0.1 s, 20 psi)
induced slower inward currents (IACh) in the voltage-clampmode (VH65mV; A1: a typical trace), and accelerated spontane-
ous firings in the current-clampmode (A2: a typical trace). B1, B2, In some neurons, ACh puffs induced faster inward currents (VH
65mV; B1: a typical trace), and transiently accelerated firings (B2: a typical trace). C, In a typical neuron, on which 0.1 s ACh
(300M) induceda slower current (left), 3 sAChevokeda currentwith slower and incompletedesensitization (right).D, In a typical
neuron, onwhich 0.1 s (300M) ACh induced a faster current (left), 3 s ACh evoked a faster current with complete desensitization
(right).E, Summaryof decay time constant, inducedby3 sAChapplication, in faster and slowernAChRcurrents (df13, t7.2,
p 0.01, unpaired t test). The numbers of recorded neurons are shown in parentheses.
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in STN neurons, we tested the pharmacological properties of
these currents (Fig. 2).
The slower-decaying IACh was blocked completely by 200 nM
DHE, a selective antagonist of 2-containing nAChRs (Fig. 2B1).
The neurons with slower-decaying IACh responded to RJR-2403, a
somewhat selective agonist for 42 nAChRs, but not to PNU-
282987, a selective agonist for 7 nAChRs (Fig. 2C1). In contrast,
the faster-decaying IACh was inhibited by 10 nM MLA (Fig. 2B2).
These same neurons responded to PNU-282987, but not to RJR-
2403 (Fig. 2C2). These data indicate that 42 nAChRs predom-
inantly mediated the slower-decaying IACh, whereas 7 nAChRs
predominantly mediated the faster-decaying IACh.
We verified the presence of 4-
containing (4*) nAChRs in the STN by
taking advantage of a knock-inmouse line
in which fully functional 4 nAChR sub-
units contain yellow fluorescent protein
(YFP) (4-YFP) (Nashmi et al., 2007).We
conducted imaging in live brain slices
from these mice and observed YFP fluo-
rescence in 	15% of STN neurons (see
Fig. 5C1), verifying the presence of 4*
nAChRs in a subset of STN neurons. To
further characterize 4* nAChR expres-
sion, we performed immunostaining of
the 4* nAChR protein, using the anti-
body to a closely related protein to YFP,
GFP, in serial parasagittal sections from
fixed brains of 4-YFP mice. Using
confocal microscopy, we detected 4*
nAChRs in some STN neurons (Fig.
2A1,A2), and the numbers of YFP-
positive STN neurons were comparable
among parasagittal sections in series
from medial to lateral.
To confirm the involvement of the 4
subunit in nAChRs mediating the slower-
decaying IACh, we tested ACh responses in
STN neurons of nAChR 4 subunit
knock-out (4-KO) mice. In 25 neurons
from such mice, we detected only faster-
decaying IACh but no slower-decaying
current. Furthermore, the faster-decaying
IACh occurred in a proportion (44%, 11
neurons, amplitude: 138 38 pA; : 54
10 ms) of neurons in 4-KO mice similar
to that observed in wild-type mice
(	40%). These data strongly suggest that
the slower-decaying IACh in STN were
predominantly mediated by4* nAChRs.
Because nicotine induces desensitiza-
tion of nAChRs on various time scales, we
also tested the desensitization of IACh in
the presence of 0.2 and 1M nicotine. Re-
petitive ACh (300 M) applications at3
min intervals evoked similar currentswith
10% variation in peak amplitude (Fig.
2D), indicating that this protocol could
prevent rundown of ACh responses. In
the presence of nicotine, 42 nAChR-
mediated IACh desensitized more quickly
and more completely than 7 nAChR-
mediated ones (Fig. 2D). The effects are concentration-
dependent. Interestingly, after 15 min washout, 7 nAChR-
mediated IACh recovered to 82% of initial level, but 42
nAChR currents showed little or no recovery (Fig. 2D).
These data indicated that 42* and 7 nAChRs predomi-
nantly mediated IACh in separate groups of STN neurons and
might modulate neuronal activity in different patterns due to their
deactivation and desensitization properties. These findings extend
previous binding assays (Schulz et al., 1991; Pimlott et al., 2004).
We did not find significant difference in the membrane proper-
ties of STNneurons expressing42*,7, or no nAChRs (Table 1).
Inmost STNneurons (nonAChRs: 73%,16of 22;7: 70%,14of 20;
42: 75%, 15 of 20, 2 0.0003, p 0.98), injection of a negative
Figure 2. Genetically assisted pharmacological characterization of nAChR subtypes in STN neurons. A1–A3, GFP antibody
staining in a PFA-fixed parasagittal brain section from either an4-YFP (A1, 10;A2, 60) or awild-typemouse (A3, 60).B1,
B2, A slower IAChwas abolished by 300 nM DHE (B1), whereas a faster IAChwas eliminated by 10 nMMLA (B2). C1, RJR-2403 (RJR),
but not PNU-282987 (PNU), evoked an inward current in an STNneuron showing a slower IACh. C2, PNU-282987, but not RJR-2403,
evokedan inward current in an STNneuron showinga faster IACh. Arrows indicate agonist applications (0.1 s, 20psi).D, Both42
and 7 nAChR currents diminished during nicotine (0.2 and 1 M) perfusion. The 42 nAChR current amplitude sharply
decreased by 68 11% (n 6) and 100% (n 5) after 10 min perfusion of 0.2 (solid triangle) and 1M (solid circle) nicotine,
respectively.7 nAChR currents diminishedmore slowly and less completely after 10min nicotine perfusion (0.2M nicotine: by
38 12%, n 5, open triangle; 1M nicotine: by 80 7%, n 5, open circle). Two-way repeated measurements were used
to compare nicotine perfusion-induced desensitization of42 and7 nAChRs. For 1M nicotine, both nAChR subtypes (df
1, F 38.7, p 0.00023) and nicotine exposure time (0, 3, and 6 min) (df 2, F 249.2, p 0.00001) significantly affected
nicotine effects. For 0.2M nicotine, both nAChR subtypes (df 1, F 7.2, p 0.028) and nicotine exposure time (0, 3, and 6
min) (df 2, F 26.0, p 0.00001) affected nicotine effects. However, only7 nAChR currents fully recovered after 15 min
washout (7: 0.2M nicotine: 101 2%of control, n 5, open triangle; 1M: 82 6%of control, n 5, open circle) (42:
0.2M nicotine: 55 19% of control, n 5, solid triangle; 1M: 0% of control, n 5, solid circle).
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current induced a hyperpolarization with a transient component,
called voltage sag, due to hyperpolarization-induced inward cur-
rent (Ih). The three types of neurons had comparable voltage sag.
After the end of the hyperpolarizing pulse, we observed that the
membrane potential transiently relaxed to a level more positive
than the previous resting potential. This depolarization lasted a
few hundredmilliseconds inmost STNneurons, as Ih deactivated
(no nAChRs: 86%, 19 of 22; 7: 70%, 14 of 20; 42: 65%, 13 of
20; 2 3.1, p 0.08). The time course of the relaxation did not
differ among the three types of neurons.
To further address themodulation ofmicrocircuits in STN by
nAChRs, we next examined GABAergic and glutamatergic syn-
aptic inputs and synaptic targets (the SN) of neurons that express
either 42 or 7 nAChRs predominantly. To simplify the de-
scription, hereafter we refer to the two neuron types as 42 and
7 neurons, respectively.
Synaptic inputs onto STN neurons are distinct between
neuronal subtypes
STN neurons are influenced by both glutamatergic and GABAergic
inputs. To test whether these synaptic inputs onto the STN are di-
verse among subtypes of STN neurons, we recorded spontaneous
inward and outward PSCs (VH50 mV), which were respec-
tively blocked by 20 M CNQX, an antagonist of non-NMDA
glutamate receptors, and by GABAzine, an antagonist of GABAA
receptors (Fig. 3A). At the beginning of each experiment, we
applied ACh onto the recorded neuron to identify the neuron
type. Interestingly, 42 neurons exhibited a twofold higher fre-
quency of sEPSCs (U  62, n1  9, n2  16, p  0.006, Mann–
Whitney Rank Sum Test), but a threefold lower frequency of
sIPSCs than 7 neurons (U  62, n1  9, n2  16, p  0.001,
Mann–Whitney Rank Sum Test) (Fig. 3B).
We attempted to mitigate any potential recording artifacts
that could arise from our recording conditions. The Nernst po-
tential of Cl is83mV, if we use a low Cl (5mM) intrapipette
solution (see Materials and Methods). The electrochemical gra-
dient, or driving force, of Cl in this recording condition might
be so small that some sIPSCs could be obscured in noise. This
may result in underestimation of the sIPSC frequency. To con-
firm the reliability of the results, we increased the driving force for
IPSCs with a higher Cl (65 mM) intrapipette solution (see Ma-
terials and Methods). The sIPSCs were recorded from voltage-
clamped STN neurons (VH65mV) in the presence of 20M
CNQX and were blocked by 10 M bicuculline, a GABAA recep-
tor antagonist. Under these recording conditions, we confirmed
that sIPSC frequency in 42 neurons was threefold lower than
that in 7 neurons (42: 1.3 0.4 Hz, n 7; 7: 5.1 1.5 Hz,
n  20, U  23, p  0.01, Mann–Whitney Rank Sum Test).
These data suggest that 42 and 7 neurons differ in the
strength of both GABAergic and glutamatergic inputs imping-
ing on them.
To determine whether these differences were driven by differ-
ential firing patterns in presynaptic neurons, or by differential
synaptic release properties, we next examined miniature IPSCs
(mIPSCs) andminiature EPSCs (mEPSCs) when neuronal firing
was eliminated by 0.5 M TTX. We found that in both neuron
types, mEPSCs or mIPSCs did not differ from sEPSCs or sIPSCs,
respectively, in either frequency or amplitude (Fig. 3C). These
data indicate that varying spike frequency in the axonal terminals
did not appear to contribute to the difference in synaptic strength
between 42 and 7 neurons.
We electrically stimulated the dorsal part of the STN and re-
corded EPSCs or IPSCs in STN neurons at the reversal potential
of Cl (80mV) or of cations (0 mV) (Fig. 3D). Using electrical
stimulation givingmaximal responses (0.2ms, 0.5mA),we quan-
tified the excitatory and inhibitory inputs to the STN neurons
when we clamped membrane potential at 80 and 0 mV, respec-
tively. We observed larger evoked EPSCs but smaller evoked IPSCs
in42 neurons than in7 neurons (Fig. 3E). The data suggest that
42 neurons received stronger action potential-dependent gluta-
matergic inputs but less GABAergic inputs than 7 neurons.
To address the circuit integration of glutamatergic and GABAergic
inputs onto STN neuron subsets, we recorded evoked PSCs
(ePSCs) at 50 mV, which was close to the baseline membrane
potentials of STN neurons.We observed PSCs that were outward
in some cells (e.g., Fig. 3F1) and inward in others (Fig. 3G1); these
were apparently compound, with two peaks (Fig. 3F1) or a shoulder
(Fig. 3G1). For cells where electrical stimulation evoked an outward
ePSC in the voltage-clamp mode, electrical stimulation delayed
spontaneous spikes (lengthened interspike intervals) (Fig.
3F2). Conversely, for cells where it evoked an inward ePSC in
voltage-clamp mode, the electrical stimulation accelerated sponta-
neous spikes (shortened interspike intervals) (Fig. 3G2).
The electrical stimulation-induced outward currents were ren-
dered inward by 10 M bicuculline, and the waveform became
monophasic. These remaining inward currents were blocked by
20 M CNQX (Fig. 3F1). These data suggest that the outward
ePSCs indicated predominance of GABAergic inputs, whereas
the inward ePSCs indicated predominance of glutamatergic in-
puts. Indeed, the resulting compound ePSCs was significantly
correlated with eEPSCs, measured at80 mV (r 0.56, n 25,
p  0.001, Spearman rank order correlation), and with eIPSCs,
Table 1. Membrane properties of STN neurons expressing different nAChRsa
Parameters
No nAChRs 7 nAChRs 42 nAChRs
n Value n Value n Value F(2) p
Vm (mV) 22 47.2 1.4 20 47.1 1.3 21 46.1 1.1 0.2 0.83
Rm (M) 22 863 98 20 793 65 19 908 104 0.4 0.88
Action potential
Frequency (Hz) 18 4.5 0.7 18 6.6 0.8 18 4.3 0.7 3.0 0.06
Half-width (ms) 22 1.4 0.1 20 1.1 0.1 19 1.1 0.1 1.97 0.14
Variability 22 0.26 0.06 20 0.25 0.03 19 0.20 0.04 0.45 0.6
AHP (mV) 22 14.8 0.6 20 17.8 1.1 19 17.1 0.8 3.6 0.03
Hyperpolarizing response
Voltage sag (mV) 16 10.4 1.6 14 9.5 1.8 15 9.5 1.2 0.13 0.82
Rebound length (ms) 19 447 106 14 568 87 13 331 105 1.2 0.32
aValues aremeanSE. Vm,Membranepotential; Rm,membrane resistance;AHP, afterhyperpolarization. Firingvariability is the ratio of SD toaverageof firing rate. TomeasureRm,weapplieda5mVhyperpolarization (0.5 s) fromaholding
potential of50mV, and Rmwas calculated fromOhm’s law. Voltage sag, transient component of the hyperpolarization in response to80 pA current injection, caused by hyperpolarization-induced inward currents (Ih). In someneurons,
a robust transient depolarization (rebound) occurred immediately after the end of the hyperpolarizing pulse. The duration of the depolarization is rebound length.
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measured at 0mV (r 0.55, n 25, p 0.0008, Spearman rank
order correlation). The ePSC amplitude was significantly cor-
related with the alteration of interspike intervals (r 0.74, n
23, p  0.0001, Spearman rank order correlation).
We observed that local electrical stimulation led to more
frequent and stronger excitation of 42 neurons but caused
more frequent inhibition of 7 neurons (Fig. 3H1, H2). Thus,
local stimulation caused excitation in a higher percentage of
42 neurons (11 of 14, 79%) than of 7 neurons (8 of 19,
42%) ( 2  4.39, p  0.04). Furthermore, instantaneous fir-
ing rates were increased to 262  35% of control in 42
neurons, and to 146  10% of control in 7 neurons (p 
0.001,42 vs 7 neurons, Mann–Whitney Rank Sum Test)
(Fig. 3H2). In contrast, local stimulation led to inhibition in a
lower percentage of 42 neurons (3 of 14, 21%) than of 7
neurons (11 of 19, 58%) ( 2 4.39, p 0.04). The 42 and
7 neurons were similarly inhibited to 52 7% and 56 5%
of control firing rates, respectively (not significantly different)
(Fig. 3H2). These results support the notion that 42 neu-
rons receive a greater proportionate share of excitation, and
7 neurons receive greater inhibition.
42 and7 nAChRs in STN neurons differentially
modulate glutamate release onto SN neurons
Wenext wanted to understandwhether the differences in the two
STN populations had functional consequences downstream to
their targets.We therefore turned our investigations to the targets
of STN neurons, the SN. We stereotaxically injected 0.1 l BDA
(10,000, 3% in saline), an anterograde tracer, in mouse STN.
After 3 weeks recovery, we detected BDA-containing fibers in
both the SNr and SNc (Fig. 4A1, A2), consistent with previous
studies showing that STN neurons project to the SN.
As mentioned previously, STN neurons are mostly gluta-
matergic (Smith and Parent, 1988). To test whether synaptic
projection of STN neurons to SNc and SNr are preserved in the
slice preparation, we recorded evoked-EPSCs from either SNr
Figure 3. Glutamatergic and GABAergic synaptic inputs are diverse among STN neurons. A, Inward and outward spontaneous postsynaptic currents, recorded with low Cl (5 mM) intrapipette
solution (see Materials andMethods) at VH50mV (left), were blocked by 20M CNQX (middle) and 10M GABAzine (right), respectively. B, The sIPSC and sEPSC frequency was lower (df
23, t 3.24, p 0.01, unpaired t test) and higher (df 23, t 3.71, p 0.01, unpaired t test), respectively, in42 neurons than in7 neurons. C, TTX did not change the frequency (left) and
amplitude (right) of sEPSCs and sIPSCs in42 (blank dots) and7 (dark gray dots) neurons (sEPSC frequency:42 vs7, df 9, t 1.41, p 0.05; sIPSC frequency:42 vs7, df 9,
t0.81,p0.05; sEPSC amplitude:42 vs7, df9, t0.85,p0.05; sIPSC amplitude:42 vs7, df9, t0.13,p0.05, unpaired t test). Local electrical stimulation evoked larger
EPSCs, but smaller IPSCs, in42neurons than in7neurons in STN.D, Typical traces;E, Summary of peak amplitude (eEPSCs:42 vs7, df 21, t 3.3, p 0.01; eIPSCs:42 vs7, df
21, t 3.7, p 0.01, unpaired t test). F1, Electrical stimulation evoked a double-peaked outward PSC (VH50mV) in an STN neuron. Bicuculline (BIC) converted this to amonophasic inward
current, whichwas blocked by CNQX. F2, Local electrical stimulation changed interspike intervals in current-clamped neurons.G1, Electrical stimulation evoked an inward PSC (VH50mV) and
accelerated firing in an STN neuron (G2).H1, Comparison of the proportions of42 and7 neurons being stimulated (black) or inhibited (gray) (
2 4.39, p 0.04).H2, Summary of electrical
stimulation-evoked increase anddecrease of instantaneous firing rates in42 (blankbars) and7 (gray bars) neurons. Number of neurons is indicated in parentheses. **p0.01; ***p0.001.
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GABAergic or SNc DA neurons by electrically stimulating STN in
thepresenceof10Mbicuculline.EvokedEPSCsweredetected inall
tested neurons in SNr (n  4) and SNc (n  3), and these EPSCs
were blocked by adding 20 M CNQX (Fig. 4B2,B3). These results
confirmedthatSTNglutamatergicprojections to theSNwereat least
partially preserved in the parasagittal slices.
We activated either42 or7 neurons with specific agonists
and recorded responses in the SN.We focally ejected 50M RJR-
2403 in STN for 5 s to stimulate 42 neurons, or 20 M PNU-
282987 in STN for 5 s to stimulate 7 neurons. We recorded
sEPSCs from voltage-clamped SNc dopaminergic neurons or
SNr GABAergic neurons (VH  65 mV). The frequency of
sEPSCs in SNrGABAergic neurons (4.6 0.7, n 14) is 2.5-fold
higher than in SNc DA neurons (1.9 0.3, n 11) (df 23, t
3.57, p  0.002, unpaired t test). Local ejection of RJR-2403 in
STN increased sEPSC frequency in SNr GABAergic neurons to
157 6%of baseline (n 17, p 0.0001; Fig. 4D1,F1), but in SNc
DA neurons to only 113 7% of baseline (n 15, p 0.6; Fig.
4E1,F1) (df  30, t  3.39, p  0.0009, SNc vs SNr, unpaired t
test). Local ejection of PNU-282987 in STN had an opposite pro-
file, increasing sEPSC frequency in SNr GABAergic neurons to
123 7% of baseline (n 14, p 0.006; Fig. 4D2), but to 160
8% of baseline (n 10, p 0.0001; Fig. 4E2) in SNc DA neurons
(df  22, t  6.1, p  0.0001, SNc vs SNr; Fig. 4F2). These data
suggest that 42 neurons preferentially stimulate downstream
SNr GABAergic neurons, whereas 7 neurons preferentially
stimulate SNc dopaminergic neurons.
Using the same puffing procedure, we applied a fluorescent
dye, DiI, into the STN for 5 s, and it spread spherically, to a radius
of 	50 m (	1/10 of STN). We applied the agonists at their
EC50, which may not maximally activate nAChRs.
Figure 4. 42 and7 neurons differentially modulate SN neurons. A1, A2, BDA (red), an anterograde tracer, injected in STN, was transported to the SN. Green neurons were TH-positive (A2).
B1, A stimulating electrode (Stim) and a recording electrode (Rec) were placed in STN and SNc or SNr, respectively. B2, B3, In the presence of 10M bicuculline, electrical stimulation in STN evoked
CNQX- sensitive EPSCs in both SNc (B2) and SNr neurons (B3). C, Either RJR-2403 (RJR, 50M) or PNU-282987 (PNU, 20M) was locally applied (5 s) to alternatively activate42 or7 nAChRs
in STN. Meanwhile, sEPSCs were recorded from either an SNr neuron or an SNc neuron. Either RJR-2403 (D1,E1,F1) or PNU-282987 (D2,E2,F2) in STN increased sEPSC frequency in SNr neurons.
PNU-282987 (D2,E2,F2), but not RJR-2403 (D1,E1,F2) in STN, increased sEPSC frequency in SNc neurons. B1, C, The rectangles in SNc and SNr indicate the area containing the recorded neurons.
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4* nAChRsmodulate firing rates of STN neuron subsets
in vivo
We performed in vivo single-unit recordings to test the expecta-
tion that STN neurons containing nAChRs would respond to
local ACh application in vivo. During single-unit recordings, ACh
(0.5 M) was delivered by iontophoresis (30 nA for 10 s) (Fig.
5A,B). We observed that ACh stimulated 21% (17 of 81) of neu-
rons (Fig. 5B).
To address receptor subtypes mediating in vivo ACh re-
sponses, we tested the effects of ACh iontophoresis on the firing
rate of STN neurons in brain slices. In this set of experiments, we
used 4-YFP mice in which 42 neurons were visibly fluores-
cent (Fig. 5C1). We consistently observed that ACh stimulated
42 neurons (Fig. 5C2,C3, top), but not other neurons (Fig.
5C2,C3, bottom). Atropine perfusion (0.5M, 5min) alteredACh
responses in neither 42 (before atropine: 186  30% of pre-
Figure 5. ACh iontophoresis directly stimulated42 neurons in vivo and in vitro. A, Single-unit recordings were performed in STN. A typical 1 s trace is shown. Calibration: 0.5 s, 150V. A
representative image shows neurobiotin staining in STN. Scale bar, 100m. B, ACh (0.5 M) was applied from the recording electrode by iontophoresis (10 s, 30 nA), and stimulated an STN neuron
(right). Left, Spike waveform. Calibration: 1ms, 100V. C1, C2, Brain slices of4-YFPmice were prepared, andwhole-cell current-clamp recordings (C2) weremade in either4-YFP-positive (C1,
top, C2, top) or4-YFP-negative (C1, bottom, C2, bottom) neurons. Scale bars: C1, 20m. C2, The square waveform under firing traces shows 10 s ACh application by iontophoresis (0.5 M ACh, 30
nA). This increased firing rate in4-YFP-positive neurons (top), but not in4-YFP-negative neurons (bottom). C3, ACh increased firing rate by 71 5% (n 7, p 0.006) in4-YFP-positive
neurons (filled circle), but not in4-YFP-negative neurons (open circle, by 8 6%, n 9, p 0.50) (4-YFP-positive vs negative neurons, df 14; t 3.9, p 0.01, unpaired t test).D1, A pair
of STN neuronswere recorded. Nicotinic responseswere detected by puffing ACh (0.1 s, 300M, 20 psi) onto neurons. Rec, Recording electrode; ACh, puffer pipette.D2, In a pair of neurons, a single
spike was evoked in one neuron in current-clampmode by injecting a depolarizing current (10 ms, 50 pA), and meanwhile signals were recorded from the other neuron in voltage-clamped mode
(VH50 mV).
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ACh, n  6; after atropine: 238  48% of pre-ACh, n  5; t 
1.89, p  0.12) nor non-42 (before atropine: 108  6% of
pre-ACh, n 11; after atropine: 97 6% of pre-ACh, n 5; t
1.52, p  0.15) neurons. These data suggest that iontophoresis
delivered ACh at low concentrations, which could activate 42
nAChRs, but not the less sensitive 7 nAChRs.
If STNneurons interact, ACh-stimulated42neurons, then,
could excite nearby STN neurons in vivo. To test this possibility,
we recorded pairs of neurons 50–100 m apart (Fig. 5D1). In
each neuron pair, we injected 10 ms 50–80 pA currents to stim-
ulate a single spike in the current-clamped neuron and recorded
signals from the voltage-clamped neuron (VH50 mV) (Fig.
5D2). The time-locked current in the voltage-clamped neuron
initiating within 0.1–0.5 ms after the peak of spike in the
current-clamped neuron indicates monosynaptic connections
(Berry and Pentreath, 1976). We ran 10 trials at 15 s intervals
in each pair, switched recording modes in two neurons, and
ran 10 trials again. In 78 pairs of STN neurons, we elicited no
time-locked postsynaptic current (Fig. 5D2). These data sug-
gest that STN neurons may not form synapses with nearby
neurons (100 m).
These results indicate that we could use ACh stimulation as an
approach to identify42 neurons in STN in vivo. Indeed, our in
vivo and in vitro recordings revealed a similar percentage (20%)
of 42 neurons in STN.
Chronic nicotine modifies nicotinic responses in
STN neurons
Previous studies show that chronic nicotine selectively upregu-
lates 42*, but not 7 nAChRs, in midbrain GABAergic neu-
rons (Nashmi et al., 2007; Xiao et al., 2009a). If upregulation also
occurs in STN, this could enhance the activity in 42 neurons.
To address this issue, we infused vehicle or nicotine into 4-GFP
mice with osmotic minipumps for 7 or 14 d and counted fluores-
cent neurons and measured fluorescent intensity in STN.
Chronic nicotine increased the number of fluorescent neurons in
STN (Fig. 6A–C) and the average fluorescent intensity of each
neuron (Fig. 6D1,D2).
We also compared nicotinic currents in STNneurons between
chronic vehicle- and nicotine-treatedmice (Fig. 6E; Table 2). We
detected larger 42 currents, but similar 7 currents, in STN
neurons from 14 d nicotine-treatedmice, than in those from 14 d
vehicle-treated mice (Fig. 6E; Table 2). Because 300 M ACh
activates the majority of 42 nAChRs, and 50% of 7
nAChRs (Chavez-Noriega et al., 1997; Gerzanich et al., 1997), the
evoked responses likely reflect the number of nAChRs.
Interestingly, both 7 and 14 d nicotine-treated mice had in-
creased proportions of42 neurons, accompanied by decreased
proportion of non-nAChR neurons (Table 3; Fig. 6F). For inter-
pretation of this phenomenon, we propose that some neurons
contain 42 nAChRs that produce little or no agonist-induced
current, either because they are intracellular, otherwise inactive,
or simply too sparse on the membrane. Chronic nicotine in-
creases the plasma membrane population of these receptors so
that nicotinic currents can be detected electrophysiologically.
After 3weekswithdrawal, the percentage of42neuronswas
still significantly higher in nicotine-treated mice than that in
vehicle-treated mice (Table 3). However, ACh-induced current
size in chronic nicotine-treated mice became the same as that in
chronic vehicle-treated mice (Table 2). The recovery in current
Figure 6. Chronic nicotine upregulates42 nAChRs in STN.4-YFP was visualized with GFP antibody staining (A, B). More4-YFP-positive neurons were found in STN of chronic nicotine-
treatedmice (B) than chronic vehicle-treatedmice (A).A,B, Insets, 60 images. C, The number of neurons per STN sectionwas greater in chronic nicotine-treatedmice.D1,D2, The integrated YFP
density in STNneuronswashigher in chronic nicotine-treatedmice.E, STNneurons in chronic nicotine-treated (14d)mice (Nicotine) had larger42nAChR currents (df43; t2.77,p0.009,
unpaired t test; K-S statistics, 0.45, p 0.05) but similar7 nAChR currents, comparedwith those in chronic vehicle-treatedmice (Vehicle). F, The 14 d nicotine treatment increased the proportion
of42 neurons (black stack) but decreased that of neurons not responding to ACh (dark gray stack) (df 2, 2 10.7, p 0.01). G, The 3M ACh induced currents in42 neurons of 14 d
nicotine-treated (right)mice, but not in those of 14 d vehicle-treated (left) mice.H1, The 14 d nicotine treatment increased spontaneous firing rate in42 neurons (df 29, t 3.39, p 0.02,
unpaired t test), but not in7 neurons (df 31, t 1.1, p 0.05). H2, In chronic vehicle- and nicotine-treated mice, ACh iontophoresis in vivo stimulated 21% (17 of 81) and 44% (38 of 86),
respectively, of STN neurons (df 1,  2 10.1, p 0.01). Spontaneous firing rate was higher in STN neurons stimulated by ACh iontophoresis in chronic nicotine-treated mice than those in
chronic vehicle-treated mice (df 53, u 196, p 0.01, Mann–Whitney test). Numbers of neurons are indicated in each box. *p 0.05; **p 0.01.
Table 2. Chronic nicotine effects on ACh currents in STN neurons
Treatment n Vehicle n Nicotine p
7 d
42 13 49 10 15 63 13 0.38
7 18 87 15 20 89 22 0.95
14 d
42 22 46 7 23 73 7 0.009
7 19 94 19 21 82 15 0.37
3 weeks withdrawal
42 11 35 6 15 43 11 0.55
7 11 93 19 9 88 22 0.86
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size of 42 nAChRs after nicotine withdrawal supports the no-
tion that nicotine upregulation of nAChRs was reversible.
Anextensive electrophysiological literature,mostlywithnAChRs
expressed in clonal cell lines, suggests that 42 nAChRs exist in
two forms (Buisson and Bertrand, 2001; Lo´pez-Herna´ndez et al.,
2004; Moroni et al., 2006; Son et al., 2009). These are termed
high-sensitivity (EC50 	 1 M) and low-sensitivity (EC50 	 90
M) forms. The high-sensitivity form is capable of being acti-
vated by the ambient ACh and can be upregulated by chronic
exposure to nicotine (Son et al., 2009; Henderson et al., 2014).
Within the technical limitations of puffer application in the slice
preparation, we studied this point for STN neurons. We chose to
study the responses to 3 M ACh, which activates some high-
sensitivity but essentially no low-sensitivity 42 nAChRs. In
such cases, an increased proportion likely reflects enhanced sen-
sitivity (rather than simple number) of upregulated nAChRs.We
applied 3 M ACh to STN neurons from both 14 d nicotine- and
vehicle-treated mice that responded to 300 M ACh with slow
currents (Fig. 6G).Wedetected 3MACh-evoked current in only
2 of 6 neurons of vehicle-treated mice (3.7  2.5% of 300 M
ACh-induced currents, n  6), but in all of 6 neurons from
nicotine-treatedmice (13.4 0.6% of 300MACh-induced cur-
rents, n 6) (p 0.01, chronic nicotine vs chronic vehicle,Mann–
Whitney Rank Sum Test). The data are consistent with the notion
thatchronicnicotineupregulateshigh-sensitivity42nAChRsand
can explain that spontaneous firing rate of42neuronswas signif-
icantly higher in 14 d nicotine-treated mice than in 14 d vehicle-
treated mice (Fig. 6H1), suggesting that 42 nAChRs on these
neurons have an enhanced response to ambient ACh.
To test whether chronic nicotine upregulation of 42
nAChRs in STN neurons modifies neural circuits and neuronal
activity in vivo, we conducted in vivo single-unit recordings from
either chronic vehicle- or nicotine-treated mice. We observed
that chronic nicotine treatment increased the proportion of neu-
rons being stimulated by ACh iontophoresis (chronic vehicle:
21%, 17 of 81; chronic nicotine: 44%, 38 of 86; 2  10.1, p 
0.001) (Fig. 6H2) and that spontaneous firing rates in ACh-
stimulated neurons were higher in chronic nicotine-treated mice
than in vehicle-treated mice (Fig. 6H2).
Synaptic inputs to STN neurons are subject to regulation by
dopamine (Shen and Johnson, 2000; Heida et al., 2008;Marani et
al., 2008). Chronic exposure to nicotine, by affecting dopamine
levels (Rahman et al., 2004; Lester et al., 2009; Zhang et al., 2012;
Koranda et al., 2014), could affect synaptic inputs to STN
neurons. To test this possibility, we analyzed spontaneous post-
synaptic currents in STN neurons in chronic vehicle- and
nicotine-treated mice. The sIPSC and sEPSC frequency in 42
and 7 neurons did not significantly differ between chronic
vehicle-treated mice (42 neurons: sIPSCs, 1.6  0.3 Hz, n 
19; sEPSCs, 2.8 0.5 Hz, n 19; 7 neurons: sIPSCs, 8.0 2.0
Hz, n 19; sEPSCs, 1.6 0.2 Hz, n 19) and nicotine-treated
mice (42 neurons: sIPSCs, 1.9 0.5Hz, n 10; sEPSCs, 3.4
0.8 Hz, n  10; 7 neurons: sIPSCs, 11.2  2.8 Hz, n  15;
sEPSCs, 2.4  0.3 Hz, n  15). Moreover, the ratios of sIPSC
frequency to sEPSC frequency in both42 and7 neuronswere
similar in chronic vehicle- and nicotine-treatedmice (42 neu-
rons, chronic vehicle: 0.71  0.11, n  19; chronic nicotine:
0.75 0.19, n 10, p 0.84, Mann–Whitney Rank Sum Test)
(7 neurons, chronic vehicle: 8.2 3.1, n 19; chronic nicotine:
7.6  3.1, n  15, p  0.59, Mann–Whitney Rank Sum Test).
These data suggest that chronic nicotine may not alter the excit-
atory and inhibitory synaptic inputs impinging on two popula-
tions of STN neurons.
Discussion
42 and7 nAChRs regulate separate microcircuits in STN
We provide electrophysiological and pharmacological evidence
showing two distinctmicrocircuits operating within the STN and
diverging into SNr and SNc. One, enhanced by the activation of
7 nAChRs, preferentially forms glutamatergic synapses onto
SNc dopaminergic neurons. The other one, augmented by the
activation of 42 nAChRs, preferentially targets SNr GABAer-
gic inhibitory neurons. Selective stimulation of the twomicrocir-
cuits may stimulate and inhibit, respectively, SNc dopaminergic
neurons.
Previous studies show that a large proportion of SN neurons
contain both 42 and 7 nAChRs (Wooltorton et al., 2003;
Xiao et al., 2009a), but in the STN, 42 and 7 nAChRs sepa-
rately exist in two distinct neuron populations (Figs. 2 and 7). STN
neurons containing 42 nAChRs displayed slower kinetics than
STN neurons containing 7 nAChRs in both deactivation and de-
sensitization (Figs. 1 and 2). Thus, the activation of 42 and 7
nAChRs excited STN neurons on the time scales of1 s and1 s,
respectively (Fig. 1). Our data also show that 42 nAChRs were
only partially desensitized during agonist application at moder-
ate concentrations (e.g., 300 M) for several seconds (Fig. 1C),
leading tomaintainedmembrane depolarization andmaintained
elevation of neuronal firing rates. Given that 42 nAChRs ex-
Table 3. Chronic nicotine effects on nAChRs in STN neurons
Treatment n None, % 42, % 7, % 2 p
Wild-type 7 d Vehicle 41 41 22 37 6.46 0.03
Nicotine 36 16 42 42
14 d Vehicle 35 38 18 44 11.5 0.003
Nicotine 57 17 51 32
3 weeks
withdrawal
Vehicle 50 38 20 42 5.97 0.05
Nicotine 23 26 48 26
4 KO Naive 25 56 — 44
Figure7. Thediversity of synaptic inputs andoutputsof STNneurons.42and7nAChRs
are the predominant nAChR subtypes in	20%and	40%of STN neurons, respectively. Com-
pared with7 nAChR-containing neurons,42 nAChR-containing neurons receive stronger
glutamatergic inputs, primarily from the motor cortex, but less GABAergic inputs from the
globus pallidus (GP).42 and7 nAChR-expressing neurons preferentially control SNr and
SNc neurons, respectively. SNr GABAergic neurons inhibit SNc neurons. Putative synaptic con-
nections defined in other publications are indicated as dashed lines.
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hibit higher sensitivity to ACh, we suggest that, in STN, 42
neurons might be among the major targets of PPTg stimulation,
which boosts therapeutic effects of STN stimulation in late-phase
PD (Stefani et al., 2007).
Beta oscillations, comprised of synchronized firings, occur in
the STN in both PDpatients and parkinsonian animals (Brown et
al., 2001; Magill et al., 2004; Priori et al., 2004; Brown and Wil-
liams, 2005; Weinberger et al., 2006). High-frequency optoge-
netic stimulation in cortical glutamatergic inputs to STN, but not
in STN neurons themselves, disrupts beta oscillations and im-
proves motor symptoms in parkinsonian animals (Gradinaru et
al., 2009). It is likely that glutamatergic inputs vary among neu-
rons, so that stimulation of glutamatergic inputs would cause
differential excitation among neurons and disrupt the oscillation.
Our data showing that42 neurons receivemore glutamatergic
inputs than 7 neurons (Fig. 3B,D,E) provide cellular and syn-
aptic evidence for this point.
In STN neurons, we also observed 2-fold less GABAergic
inputs in 42 than in 7 neurons (Fig. 3B,D,E). As GABAergic
terminals synapsing onto STN neurons originate in the globus
pallidus (Loucif et al., 2005; Benarroch, 2008; Marani et al.,
2008), these data suggest that 7 neurons receive more GABAe-
rgic inputs than 42 neurons (Fig. 7).
We found that 42 neurons receive more glutamatergic in-
puts and less GABAergic inputs comparedwith7 neurons (Figs.
3 and 7). Electrical stimuli in STN increased firing rate in more
42 neurons than 7 neurons (79% vs 42%) while inhibiting
firing rate inmore 7 neurons than 42 neurons (58% vs 21%)
(Fig. 3H1). This suggests that local electrical stimulation may
differentially alter neuronal activity in STN.
42 and 7 neurons were disparate, not only in synaptic
inputs, but also in their major synaptic targets. Stimulating 42
neurons caused a greater enhancement in glutamatergic inputs to
SNr GABAergic neurons, but stimulating 7 nAChRs caused a
greater enhancement in glutamatergic input to SNc DA neurons
(Fig. 4). Because SNr GABAergic neurons inhibit SNc DA neu-
rons (Tepper et al., 1995), selectively enhancing the activity of
42 neurons in STN may indirectly inhibit SNc DA neurons.
These data extended the previous finding that electrically
stimulating STN neurons induces a complex postsynaptic po-
tential waveform in SNc DA neurons, with an STN-SNc
monosynaptic glutamatergic EPSP and an STN-SNr-SNc
polysynaptic GABAergic IPSP (Iribe et al., 1999).
Consideringourdata shown inFigures 1, 2, 3, and4with those in
Figure 5D2 showing no synaptic interaction between STN neurons,
we propose that, in the STN, there are at least two rather divergent
microcircuits involving 42 or 7 neurons (Fig. 7). As local elec-
trical stimulation lacks selectivity toward synaptic projections from
different nuclei, further investigations arewarranted touse cell type-
specific manipulations to characterize the differential inputs from
motor cortex/PPTg and from the globus pallidus/SNr, which is es-
sential to fully address the circuit patterns.
Some nAChRs containing 4 and 2 subunits govern volun-
tary movement, via activation of these nAChRs on SNc DA neu-
rons and on DA terminals in the striatum (Labarca et al., 2001;
Tapper et al., 2004; Nashmi et al., 2007; Drenan et al., 2008, 2010;
Xiao et al., 2009a;Quik andWonnacott, 2011;Drenan andLester,
2012). Our data provide an additional pathway: a subpopulation
of STN neurons can be stimulated by nicotinic agonists selective
for 42* nAChRs andmay consequently excite SNr GABAergic
neurons, which could increase inhibitory tone to SNc DA neu-
rons. This pathwaymight be important in fine-tuning the activity
of SNc DA neurons.
Chronic nicotine modifies 42 nAChRs in STN neurons
Similar to previous studies in other brain regions (Nashmi et al.,
2007; Lester et al., 2009; Son et al., 2009; Xiao et al., 2009a; Srini-
vasan et al., 2011; Henderson et al., 2014), chronic nicotine up-
regulated both the number and sensitivity of 42* nAChRs in
STN (Fig. 6D1,D2,E,G; Table 2). Interestingly, chronic nicotine
increased the percentage of 42-containing neurons; thus,
there were functional nAChRs in neurons not previously re-
sponding to ACh (Fig. 6F,H2; Table 3). These results can be
explained by previous findings show that many 42 nAChRs
reside in intracellular organelles and that nicotine acts as a phar-
macological chaperone to facilitate receptor assembly, so that
additional receptors appear both in organelles and on the plasma
membrane (Lester et al., 2009; Miwa et al., 2011; Richards et al.,
2011; Srinivasan et al., 2011, 2012; Henderson et al., 2014). This
upregulation may especially occur in somatodendritic regions,
which give the largest signals in whole-cell recordings.
The upregulation of 42* nAChRs by chronic nicotine en-
hanced responses to basal levels of ACh and increased firing rate
in 42 neurons, but not in 7 neurons (Fig. 6H1,H2). Because
chronic nicotine changed synaptic inputs neither in 42 neu-
rons nor in 7 neurons, the increased firing in 42 neurons by
chronic nicotinemight be primarilymediated by the upregulated
nAChRs in the somata or dendrites of these neurons. According
to the neural circuit diagram in Figure 7, the contrast in chronic
nicotine effects on 42 and 7 neurons could exaggerate gluta-
matergic inputs to SNrGABAergic neurons over those to SNcDA
neurons. The effect is demonstrated by our observation that,
compared with vehicle-treated mice, chronic nicotine-treated
mice had higher sEPSC frequency in SNr GABAergic neurons
(vehicle: 5.0 0.6Hz, n 18; nicotine: 8.3 1.1Hz, n 13, p
0.006), but similar sEPSC frequency in SNcDA neurons (vehicle:
1.2  0.3 Hz, n  10; nicotine: 1.5  0.4, n  8; p  0.24).
Together with the fact that chronic nicotine upregulates 42*
nAChRs in SNr GABAergic neurons, but not SNc DA neurons
(Nashmi et al., 2007; Xiao et al., 2009a), we propose that chronic
nicotine enhances the activity of SNr GABAergic neurons through
upregulating 42* nAChRs in both their somata and presynaptic
STN glutamatergic neurons. This consequently could lead to a sup-
pression and protection of SNc DA neurons (Nashmi et al., 2007;
Lester et al., 2009; Xiao et al., 2009a) because GABAergic inhibition
protects neurons from excitotoxicity (Luo et al., 2002).
That chronic nicotine suppresses firing in SNc DA neurons is
consistent with decreased dopamine release in the striatum of
chronic nicotine-treated animals, observed in previous in vivo
microdialysis and in vivo cyclic voltammetry studies (Rahman et
al., 2004; Zhang et al., 2012; Koranda et al., 2014). In addition, in
chronic nicotine-treated animals, even when DA neuron firing
frequency is directly controlled by stimulating the SN, impulse-
evoked striatal dopamine release is almost as low as in 2 knock-
out mice (Koranda et al., 2014). It was suggested that unknown
adaptive mechanisms associated with chronically desensitized
nAChRs, or with these low striatal DA levels, participate in the
apparent neuroprotective effects of chronic exposure to tobacco
products (Koranda et al., 2014).
The upregulation of42* nAChRs in STN leads to a selective
enhancement of the activity in 42 neurons (Fig. 6H1,H2). This
consequently could decrease the probability of synchronized fir-
ing, which is associated with increased beta oscillations in local
field potentials, motor symptoms, and L-dopa-induced dyskine-
sia in PD (Kreiss et al., 1997; Lozano et al., 2000; Levy et al., 2001,
2002; Weinberger et al., 2006). This could be a possible circuit
mechanism underlying the phenomenon that chronic nicotine
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partially alleviates L-dopa-induced dyskinesia in parkinsonian
animal models (Huang et al., 2011). Drugs selective for 42*
nAChRs could represent better candidates than nicotine because
these drugs, if chronically applied, effectively upregulate 42*
nAChRs (Gopalakrishnan et al., 1997; Srinivasan et al., 2014) and
avoid the disadvantages of nicotine: lack of selectivity for nAChR
subtypes and rapid metabolism.
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